Bangladesh and the U.S. have signed a pivotal trade agreement, slashing tariffs to 19% and lifting barriers on specific textiles and apparel. The accord fosters cooperation in industrial sectors while ...

Worth up to $2.4 billion, the acquisition is also the latest in a series of buyouts involving startups with technologies that modify immune cells inside the body.

PASADENA, Calif., Feb. 9, 2026 /PRNewswire/ -- Bidding opens on February 11 in a major Tiger Group biopharma-industry auction of new and late-model GMP Manufacturing and Quality Control Laboratory ...

Unfortunately, this Budget does not provide any belief that India is investing in a knowledge-based system that will advance science and technology and embed this in advanced production. So let us ...

The agency’s program will be open to pharmaceutical facilities that align with “national priorities.” Elsewhere, a ...

Strategic amendment transforms regional partnership into global collaboration; Newsoara gains exclusive worldwide license to develop and ...

Pune: Pune, long known for its dominance in vaccine manufacturing and life-sciences research, is steadily emerging as a key hub for advanced biologics.

Finance Minister Nirmala Sitharaman's ninth consecutive Union Budget focused heavily on healthcare development across the country by increasing medication production, medical tourism, Ayurveda, yoga, ...

How is the biopharmaceutical sector evolving, and where are opportunities for advancement? The biopharma sector has undergone significant change over the last 30 years, and it’s set to continue seeing ...

In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a leading generics drugmaker. Now with its innovative drug franchise ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...